Introduction
============

Clear lens extraction (CLE) to correct high myopia is a technique that is used in cases in which phakic intraocular lens (IOL) implantation is contraindicated. The risk of retinal detachment is a concern in this procedure.[@b1-opth-4-155]--[@b3-opth-4-155] In order to decrease the intraocular complications related to posterior capsule rupture, and subsequent vitreous loss with increased incidence of retinal detachment (RD),[@b4-opth-4-155] supracapsular phacoaspiration is used. Supracapsular phacoaspiration is a 'capsule-friendly' technique in spite of its effect on the endothelial cell count (ECC).[@b5-opth-4-155] In our study we compared supracapsular and endocapsular phacoaspiration by the divide and conquer (D and C) technique, the latter being less traumatic to ECC.[@b6-opth-4-155]

Patients and methods
====================

This was a nonrandomized prospective study that included 40 eyes of 20 patients who presented for the treatment of high myopia. Inclusion criteria were: myopia more than 10 diopters in both eyes, and patients not suitable for laser in situ keratomileusis (LASIK). The exclusion criteria were patients with previous history of RD, glaucoma, uveitis, ocular trauma, or previous ocular surgeries. Patient who were unfit for LASIK, but could not afford phakic IOLs, were allowed to enroll for this study. The patients were divided into 2 groups: group A underwent supracapsular phacoaspiration, and group B was the contralateral eyes of the same patient. These patients were operated on with endocapsular phacoaspiration by the D and C technique.

Preoperative full ocular examination was conducted, including uncorrected visual acuity (UCVA) and best corrected visual acuity (BCVA), through slit lamp biomicroscopy of the anterior segment, dilated ocular examination to note the state of the lens, the vitreous, and a 3-mirror examination of the retinal periphery. Special note was taken of the vitreous. This was performed by allowing adequate dark adaptation of the examiner, off-axis slit beam and the use of a 3-mirror contact lens.

In cases where there was clinical evidence of posterior vitreous detachment, attempts were made to document this while performing the biometry, by switching to the B-mode of the ultrasonic machine and searching for a mobile thin membrane not attached to the optic nerve head which disappeared on increasing the gain. Patients that had flat tears or retinal thinning were treated with Argon laser and postponed. Patients with suspicious maculae underwent fluorscein angiography to exclude subretinal neovascular membrane.

Corneal topography was done in all cases. Preoperative specular microscopy using the noncontact specular microscope (NONCON ROBO-P, Konan Medical) was done and repeated 6 weeks postoperatively. IOL power was calculated according to the Sanders-Retzlaff-Kraff II formula (SRK II).

Patients underwent surgery under local peri-bulbar anesthesia and sedation. A standard 3-port phacoaspiration was performed with the clear cornea incision in the steepest meridian as determined by topography. In group A during the hydro-dissection step the lens matter was expressed into the anterior chamber and phacoaspiration was done in the supracapsular space, aided sometimes with pulses of phacorespiration to facilitate and accelerate the procedure. The settings used were (vacuum 300 mmHg, flow rate 22 mm/min, Phaco power 50% pulsed mode, and bottle height 80 cm). In group B after hydro-dissection, endocapsular phacoaspiration was done using the D and C technique with the following settings: step 1: vacuum 70 mmHg, flow rate 22 mm/min, phacorespiration power 70% continuous mode, and bottle height 80 cm; step 2: vacuum 250 mmHg, flow rate 22 mm/min, phacorespiration power 50% pulsed mode, and bottle height 80 cm). Irrigation/aspiration (I/A) in both groups was done with the following settings (vacuum 400 mmHg, flow rate 25 mm/min). Implantation of foldable hydrophobic acrylic IOL with an overall diameter 13 mm were implanted in the capsular bag and in the ciliary sulcus in cases of posterior capsule rupture. Anterior vitrectomy was done in cases with ruptured capsule through the paracentesis incisions. There was an interval of 3 weeks between both eyes.

Intraoperative data included phacorespiration time, capsule rupture, nucleus cracking, and unstable anterior chamber with repeated collapse. Postoperative examination was done on days 1, 2, 3, 7, 14 and then after 6 weeks and every 3 months. Postoperative data including UCVA, BCVA, intraocular pressure (IOP), anterior chamber reaction, cystoid macular edema (CME), posterior capsule opacification (PCO), and retinal tears or detachment were recorded.

The results were analyzed using the SPSS computer software package, version 10.0 (Chicago, IL, USA). Continuous data were expressed as means with standard deviation. For comparison within and between the groups, the paired t-test and the Student's t-test were used, respectively. Qualitative data were summarized using frequencies and percentages. The two groups were compared using Fisher's exact test. All tests were two tailed and considered statistically significant at *P* \< 0.05.

Results
=======

Mean age was 35.650 ± 5.8515 years; mean follow-up time is 17.1 ± 8.564 months. Mean myopia was −17.3 ± 5.069 diopters in group A and −17.9 ± 4.204 diopters in group B. Mean preoperative UCVA was 0.04 + 0.0167, and mean postoperative UCVA was 0.435 + 0.1442. Pre- and postoperative BCVA and ECC are given in [Tables 1](#t1-opth-4-155){ref-type="table"} and [2](#t2-opth-4-155){ref-type="table"}. There was a significant difference between pre- and postoperative BCVA within both groups ([Table 1](#t1-opth-4-155){ref-type="table"}), but not between the two groups.

Within both groups pre- and postoperative ECC was differed significantly ([Table 2](#t2-opth-4-155){ref-type="table"}), but postoperative ECC did not differ significantly between the two groups in ([Table 3](#t3-opth-4-155){ref-type="table"}). Phacorespiration time for group A was 4.6 ± 1.6 seconds; for group B it was 9.90 ± 2.27 (significant, *P* \< 0.000) ([Table 3](#t3-opth-4-155){ref-type="table"}). No cases of capsule rupture occurred group A, but 3 cases occurred in group B (15%) (not significant between groups, *P* = 0.231). In group A no difficulty was experienced with nucleus cracking, as we did not need to crack the nucleus. In group B there were difficulties in nucleus cracking, as cheese-wiring occurred because the second instrument used to manipulate the nucleus was able to go through rather than crack the soft nucleus. This occurred in 13 cases (65%). Chamber collapse occurred in 4 cases (20%) in group A and in 5 cases (25%) in group B (not significant, *P* = 1.000). Moderate postoperative iritis was recorded in group B in the 3 cases (15%) that had posterior capsular rupture. No cases of iritis were recorded in group A (not significant, *P* = 0.231). CME was recorded in 2 cases in group B (10%) and none in group A (not significant, *P* = 0.487).

RD was not recorded in either group. Two eyes in group A and 3 eyes in group B underwent preoperative Argon laser treatment for flat tears but no cases underwent any further treatment postoperatively. Until exit from the study, we noted the occurrence of PCO at every follow-up visit. No cases of PCO that affected visual acuity were recorded in the sample studied.

Discussion
==========

The main concern in highly myopic eyes undergoing CLE is RD.[@b1-opth-4-155],[@b7-opth-4-155] The incidence of RD is related to rupture of posterior capsule and vitreous loss.[@b8-opth-4-155] No RD was seen in any of our cases. This can be explained by: 1) the short follow-up period in our study (17.1 ± 8.564 months), as the incidence of RD tends to occur at later stages;[@b3-opth-4-155] 2) the meticulous pre-operative selection, as all patients had a thorough 3-mirror examination of the retinal periphery; 3) the fact that none of the cases had an yttrium aluminium garnet (YAG) capsulotomy. It has been documented that RD incidence increases after YAG laser posterior capsulotomy.[@b3-opth-4-155],[@b7-opth-4-155] The combined effect of these three factors may contribute to the absence of RD cases in our study. The absence of cases of PCO in our series can again be attributed to the short follow-up period and also to the design of the IOL used in the study.

In our study we tried to compare efficacy and safety of supracapsular with that of endocapsular phacoaspiration. Supracapsular was more effective in our study, as manifested by the significant difference in phacoaspiration power that was used in both groups, which is in accordance with the results of Maloney et al.[@b5-opth-4-155] When we considered safety we evaluated two factors: ECC and posterior capsule integrity.

The endocapsular technique always poses less risk to the corneal endothelium in terms of ECC,[@b5-opth-4-155] but in our study there was no significant difference between the two groups. This can be explained by the fact that the patients were young with healthy endothelium, the lens matter was soft with a clear lens extraction, and the patients had high myopes and deep anterior chambers. Therefore, so in spite of performing the technique in a more anterior plane, we were still relatively far from the corneal endothelium compared to a more shallow anterior chamber in eyes with a lower axial length.

Anterior chamber stability may be lower in myopic eyes, because of a lower scleral rigidity, and the deeper anterior chamber necessitates tilting of the phacoaspiration probe, which places stress on the posterior lip of the phacoaspiration wound and may allow for wound leak. Also, intraocular fluidics are different in myopic eyes. An unstable anterior chamber in which the probe is further away from the posterior capsule would, logically, allow for a higher margin of safety. Chamber stability did not differ significantly between the two groups (20% and 25%, respectively), yet all cases that had a ruptured posterior capsule also showed intraoperative chamber instability.

Integrity of the posterior capsule during the procedure did not differ significantly between the two techniques. However, the three cases of capsule rupture that occurred in the endocapsular group showed a relatively longer phacoaspiration time (9, 12, 13 seconds). Also the proximity to the posterior capsule of the phacoaspiration tip may increase the incidence of posterior capsule injury. In the supra capsular group these two factors, which threaten the integrity of the posterior capsule, are greatly minimized because a shorter phacoaspiration time is more efficient.[@b5-opth-4-155] Also the phacoemulsification tip is further away from the posterior capsule.

Conclusions
===========

Placing the phacoaspiration probe in a more anterior plane, in a relatively unstable environment, would allow for a higher margin of safety. Although such a position would be harmful to the corneal endothelium, this study showed that the risk to the corneal endothelium was did not differ significantly between both techniques, and even a marginal increase in the rate of ECC loss would be offset by the reduced occurrence of posterior capsule rupture with the more posterior placement of the phacoaspiration probe. Thus supracapsular phacoaspiration is a capsule-friendly technique. Although this comes at a cost to the corneal endothelium, the cost is marginal.
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###### 

Pre- and postoperative best corrected visual acuity (BCVA)

                                           **Preoperative BCVA**   **Postoperative BCVA**   ***P***
  ---------------------------------------- ----------------------- ------------------------ ---------
  Supracapsular phacoaspiration (n = 20)   0.375 ± 0.102           0.655 ± 0.123            0.000
  Endocapsular phacoaspiration (n = 20)    0.380 ± 0.009           0.590 ± 0.186            0.000

###### 

Pre- and postoperative endothelial cell count (ECC)

                                           **Preoperative ECC**   **Postoperative ECC**   ***P***
  ---------------------------------------- ---------------------- ----------------------- ---------
  Supracapsular phacoaspiration (n = 20)   3212.8 ± 307.98        3080.1 ± 326.01         0.000
  Endocapsular phacoaspiration (n = 20)    3220.25 ± 270.84       3065.50 ± 262.62        0.000

###### 

Postoperative best corrected visual acuity (BCVA), endothelial cell count (ECC) and phaco time

                         **Supracapsular phacoaspiration (n** = **20)**   **Endocapsular phacoaspiration (n** = **20)**   ***P***
  ---------------------- ------------------------------------------------ ----------------------------------------------- ---------
  Postoperative BCVA     0.655 ± 0.123                                    0.590 ± 0.186                                   0.201
  Postoperative ECC      3080.1 ± 326.01                                  3065.50 ± 262.62                                0.877
  Phacoaspiration time   4.6 ± 1.6                                        9.90 ± 2.27                                     0.000
